Endo Will Launch the Simulator at the American Urological Association (AUA) Annual Meeting
MALVERN, Pa., April 24, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of a Spatial Computing Injection Simulator for Peyronie's disease. The simulator allows urology specialists to interact simultaneously with both physical and digital objects—blending a physical penile model and digital content via an Apple Vision Pro app—to help refine their injection technique. Endo will launch the experience at the American Urological Association (AUA) Annual Meeting, the largest gathering of urologists in the world, which takes place April 26-29, 2025.
"We know that healthcare providers value hands-on approaches to learning, and technology like the Spatial Computing Injection Simulator can make a huge difference for the surgeons and advanced practice providers who treat Peyronie's disease," said Justin Mattice, Senior Vice President & General Manager, Branded Specialty at Endo. "With a mix of tactical practice, videos of real procedures, and the inclusion of practical information, the simulator is an example of innovation that can enhance patient care."
The Spatial Computing Injection Simulator was designed to help urology specialists refine their injection technique in the penis for the administration of XIAFLEX® (collagenase clostridium histolyticum), the only FDA-approved nonsurgical treatment for Peyronie's disease.
Do not receive XIAFLEX® if you have had an allergic reaction to collagenase clostridium histolyticum or any of the ingredients in XIAFLEX®, or to any other collagenase product.
During the immersive, 20-minute Spatial Computing Injection Simulator experience, urology specialists receive hands-on practice on product reconstitution and injection angles, watch procedures in action, practice their injection technique on the penile model, and acquire information on the post-injection process. This can help them refine their technique for the treatment of real patients with XIAFLEX, which represents an important treatment option to help appropriate patients.
This is the second time Endo has used the power of spatial computing (also called "mixed reality") to create an immersive learning environment for healthcare providers. The first was developed for hand specialists who treat patients with Dupuytren's contracture.
Endo worked with technology agency Lucid Dream to create the Apple Vision Pro app and spatial computing experience.
About Peyronie's Disease
Peyronie's disease (PD) is a condition in which a buildup of fibrous scar tissue causes a curvature deformity of the penis. This curvature can be bothersome during arousal and intimacy. It is estimated that PD can affect as many as 1 in 10 men in the U.S., but diagnosis rates remain low because men with PD may be too uncomfortable to speak up and get help.
IMPORTANT SAFETY INFORMATION
Do not receive XIAFLEX if:
XIAFLEX can cause serious side effects, including:
- PENILE FRACTURE (corporal rupture) or other serious injury to the penis...
- Hypersensitivity reactions, including anaphylaxis...
- Back pain reactions...
- Fainting...
What should I avoid while receiving XIAFLEX? Avoid situations that may cause you to strain your stomach (abdominal) muscles...
What is XIAFLEX?
XIAFLEX is a prescription medicine used to treat adult men with Peyronie's disease who have a "plaque" that can be felt and a curve in their penis greater than 30 degrees when treatment is started. It is not known if XIAFLEX is safe and effective in children under the age of 18.
About Endo
Endo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies...
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements including, but not limited to, the statements by Mr. Mattice...
SOURCE Endo, Inc.
